Inflammation Linked to Inferior Outcomes in Leukemia

WEDNESDAY, Jan. 18, 2023 -- A unique inflammation signature, in which atypical B cells are identified, is associated with worse outcomes in patients with acute myeloid leukemia (AML), according to a study published online Jan. 11 in Nature...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news